FlowTriever for Acute Massive Pulmonary Embolism (FLAME)

NCT04795167 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 115

Last updated 2025-04-30

Study results available
· View outcomes & findings →

Summary

To evaluate treatment outcomes of patients diagnosed with high-risk (massive) pulmonary embolism

Conditions

  • PE - Pulmonary Embolism
  • PE - Pulmonary Thromboembolism

Sponsors & Collaborators

  • Inari Medical

    lead INDUSTRY

Principal Investigators

  • Mitchell Silver, MD · OhioHealth Riverside

  • James Horowitz, MD · NYU Langone Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-16
Primary Completion
2022-12-19
Completion
2022-12-19

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04795167 on ClinicalTrials.gov